Leeco Diagnostics, Inc.
United StatesFDA applicant, unverified
- Devices
- 50
What Leeco Diagnostics, Inc. makes
Leeco Diagnostics, Inc. manufactures in vitro diagnostic (IVD) test kits for quantifying and detecting hormones and biomarkers, including human chorionic gonadotropin (HCG), luteinizing hormone (LH), ferritin, follicle-stimulating hormone (FSH), prolactin (PRL), glycated hemoglobin (HbA1c), Epstein-Barr virus (EBV), thyroid-stimulating hormone (TSH), digoxin, and estradiol (E2). Products include enzyme immunoassays (EIA), lyophilized assays, and radioimmunoassays (RIMA) for clinical and research use.
The company’s diagnostic test kits are regulated under the FDA’s Class I and Class II device classifications, with most products requiring 510(k) clearance. These devices are listed in the FDA’s 510(k) registry, and the manufacturer is based in the United States.
Catalogue
Search and filter all 50 devicesFrequently asked questions
How many devices does Leeco Diagnostics, Inc. have in the registry?
The registry currently lists 50 devices for Leeco Diagnostics, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Leeco Diagnostics, Inc.'s devices?
Among its 50 most recently registered devices, Leeco Diagnostics, Inc. has devices listed in FDA 510(k) (50 devices).
What risk classes do Leeco Diagnostics, Inc.'s devices fall under?
Among its 50 most recently registered devices, the classes recorded for Leeco Diagnostics, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Leeco Diagnostics, Inc. in the registry?
The most recently registered devices listed for Leeco Diagnostics, Inc. include VIS-CUBE HCG (EIA) LYOPHILIZED JPL-044, LEE-BEAD BETA LH (EIA), LEECO FERRITIN-QUANT DIAG. TEST KIT and LEECO FSH-QUANT DIAGNOSTIC KIT.